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Introduction
Caveolae, small uncoated pits in the plasma membrane, are an
abundant feature of many highly differentiated mammalian
cells, such as adipocytes, endothelial cells and muscle cells
(Fig. 1). Although caveolae were described morphologically in
the early 1950s (Palade, 1953; Yamada, 1955), only recently
have some of their functions been revealed. Studies of mice
lacking isoforms of the caveolar protein caveolin suggest roles
for these structures in lipid uptake and regulation, transcellular
transport in endothelial cells, and tumour suppression (Drab et
al., 2001; Razani et al., 2002a; Schubert et al., 2001). Caveolae
have also been shown to provide a vehicle for the entry of
certain viruses into animal cells (Pelkmans and Helenius,
2002). Other work indicates that mutations in the muscle-
specific form of caveolin, caveolin-3, cause muscle disease
(Engelman et al., 1998). Despite these advances, the
relationship between the unique, highly conserved structure of
caveolae and their physiological functions remains unclear.
Here we focus on the mechanisms involved in the formation
of caveolae. Caveolae are defined by the presence of caveolins
and their unique structure, as viewed by electron microscopy
(EM) (see Figs 1 and 2). They are considered to be a
specialised, morphologically distinguishable form of lipid raft
(Rajendran and Simons, 2005; Simons and Toomre, 2000). As
discussed below, cholesterol, a crucial component of lipid rafts,
is also a vital structural feature of caveolae. Caveolae represent
a fascinating model for examining how membrane proteins
interact with lipids, how lipid microdomains are generated, and
how lipid-protein interactions and lipid rafts can contribute to
membrane morphogenesis. Moreover, insights into the
formation of caveolae also have implications for the formation
of microdomains in many different membrane systems, as well
as for our understanding of disease. For example, the
developing transverse tubule system of muscle, a surface-
connected network of tubules that penetrate the muscle fibre,
is enriched in caveolin-3 (Parton et al., 1997), and numerous
mutations in this protein have been discovered in patients
suffering from a wide range of muscle diseases (Minetti et al.,
1998) (Fig. 3). Understanding the effects of these mutations on
the normal function of the protein requires an understanding of
the precise molecular mechanisms involved in caveolae
formation and function. Conversely, the study of the mutants,
which have changes in evolutionarily conserved amino acids,
are providing new insights into caveolins and caveolae.
Caveolar structure
Caveolae each comprise a caveolar bulb (approximately 65 nm
in diameter) connected to an opening of fairly constant
diameter (approximately 45 nm in fast-frozen, freeze-
substituted adipocytes) (M. Floetenmeyer, C. Ferguson, B.
Marsh and R.G.P., unpublished). In many tissues, multiple
caveolae are arranged around a central vacuolar domain. In
adipocytes this arrangement is particularly striking and huge
surface-connected vacuolar domains are covered in numerous
caveolae (Parton et al., 2002) (Fig. 1). In developing muscle
fibres, multiple caveolae are connected by a single neck to the
plasma membrane, producing large chains of interconnected
caveolae (Parton et al., 1997). The mechanisms underlying the
formation of these tissue-specific structures are not yet defined,
although recent studies suggest that complex rosettes of
caveolae are formed when caveolae fuse (Pelkmans and Zerial,
2005). Another structural feature of caveolae in certain
endothelia is the presence of a stomatal diaphragm in the neck
of the caveolae, which is generated by the protein PV1 (Stan
et al., 2004). This fascinating specialisation is discussed
elsewhere (reviewed by Stan, 2005).
The caveolar invagination appears to be uncoated (compared
with clathrin-coated structures) in many micrographs (Fig. 1)
but, under appropriate preparation conditions, a type of coat
structure can be visualised by EM. Scanning EM and freeze-
Caveolae are striking morphological features of the plasma
membrane of mammalian cells. Caveolins, the major
proteins of caveolae, play a crucial role in the formation of
these invaginations of the plasma membrane; however, the
precise mechanisms involved are only just starting to be
unravelled. Recent studies suggest that caveolae are stable
structures first generated in the Golgi complex. Their
formation and exit from the Golgi complex is associated
with caveolin oligomerisation, acquisition of detergent
insolubility, and association with cholesterol. Modelling of
caveolin-membrane interactions together with in vitro
studies of caveolin peptides are providing new insights into
how caveolin-lipid interactions could generate the unique
architecture of the caveolar domain.
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etch replica techniques have revealed striations that form a
spiral around the cytoplasmic surface of the caveolar
invagination (Peters et al., 1985; Rothberg et al., 1992; Stan,
2002). Densities corresponding to these structures are not seen
routinely in plastic sections but can be visualised under optimal
conditions (see Fig. 2). The molecular composition of this coat
remains unknown but it has been proposed that the filaments
might comprise oligomers of caveolin (Monier et al., 1995;
Peters et al., 1985; Rothberg et al., 1992). Caveolin oligomers
can be produced in vitro or purified from tissues (Monier et al.,
1995). The oligomers have a distinctive ‘necklace’ appearance
similar to that of the spiral coat. Indeed, purified fragments
corresponding to the N-terminal cytoplasmic domain of
caveolin-1 (residues 1-101; see Figs 1 and 3) form oligomers
that can assemble into filaments (Fernandez et al., 2002) and
could correspond to the striated structures of the caveolar coat.
Such a model, in which caveolin forms the striations that
encircle the caveolar bulb is, however, at variance with the
suggestion that caveolin associates only with the neck of the
caveolae (Thorn et al., 2003), but is consistent with a recent
freeze-fracture study that localised caveolin to a belt around
the membrane-proximal region of the caveolar domain of
mouse fibroblasts (Westermann et al., 2005).
The role of caveolins in caveolae formation
The expression of caveolin-1 in cells normally lacking
caveolae causes the formation of caveolae (Fra et al., 1995) in
various different experimental systems (Breuza et al., 2002;
Kirkham et al., 2005; Lipardi et al., 1998; Vogel et al., 1998)
and studies showing loss of caveolae in mice lacking caveolin-
1 or caveolin-3 confirm the importance of caveolins in this
process (Drab et al., 2001; Galbiati et al., 2001). With only a
few notable exceptions (see below), caveolin-1 expression
correlates qualitatively with the formation of caveolae in non-
muscle cells: tissues that exhibit high caveolin expression have
a high density of caveolae, whereas those lacking caveolin-1
lack caveolae (Parton, 1996). Both caveolin-1 and the closely
Journal of Cell Science 119 (5)
Fig. 1. Caveolae and caveolin
structure. Main panel: caveolae in a
differentiated 3T3-L1 adipocyte
labelled with an electron-dense
marker to delineate the cell surface.
Note the uniform size and shape of
caveolae (some are indicated by
arrowheads) and the numerous
caveolae around larger surface-
connected vacuoles (asterisks).
Lower left: caveolae (arrowheads)
in a primary fibroblast shown in a
conventional plastic section. Top
right: a similar image at higher
magnification. Lower right: sheets
of plasma membrane from
adipocytes labelled for caveolin-1
followed by 10 nm protein-A–gold.
Note the unlabeled clathrin-coated
structure (double arrowheads). The
schematic shows the main features
of caveolin association with the
plasma membrane; positively
charged (+) and aromatic (•) amino
acids in the scaffolding domain
interact strongly with the
membrane; schematic modified
from Arbuzova et al. (Arbuzova et
al., 2000). Cholesterol may be
enriched in the scaffolding-domain-
associated portion of the membrane.
Bars, 100 nm.
Fig. 2. The caveolae ‘coat’. The images show the spiked caveolar
coat (left; red dots indicate spikes) as compared with the classical
clathrin coat (right) in sections of baby hamster kidney (BHK) cells.
The ultrathin plastic sections (<30 nm thickness) allow detection of
the coat, which is normally difficult to visualise by conventional EM
techniques (compare with Fig. 1). Bars, 100 nm.
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related isoform caveolin-3 can form caveolae when expressed
in cells lacking caveolae (Kirkham et al., 2005). Caveolin-1 is
expressed in most non-muscle tissues and in smooth muscle,
and is essential for the formation of caveolae in these tissues
(Drab et al., 2001). By contrast, loss of caveolin-2, which is
generally expressed together with caveolin-1, does not appear
to affect formation of caveolae (Razani et al., 2002b) although
caveolin-2 might facilitate caveolae formation by caveolin-1
(see below). Caveolin-3 is normally expressed in skeletal
muscle, some smooth muscle cells and in cardiac muscle (Tang
et al., 1996; Way and Parton, 1995). Caveolin-3-knockout mice
have no detectable caveolae in their skeletal and cardiac
muscle, which is consistent with caveolin-3 taking the place of
caveolin-1 in those tissues (Galbiati et al., 2001). Caveolae
formed by heterologous expression of caveolin-1 or caveolin-
3 are morphologically identical (M. Kirkham and R.G.P.,
unpublished; T. Fujimoto, A. Carozzi and R.G.P.,
unpublished).
Given the studies discussed above and the high
concentration of caveolin in caveolae (100-200 caveolin
molecules per caveola) (Dupree et al., 1993; Pelkmans and
Zerial, 2005), caveolin-1 and caveolin-3 might be structural
proteins involved directly in the bending of the membrane to
generate caveolae. Alternatively, the shape of the caveolar
domain might be generated independently of caveolins but
stabilised by caveolin or another protein (e.g. dynamin) (Nabi
and Le, 2003).
Caveolin biosynthesis and trafficking
All three caveolins generally behave as integral membrane
proteins, although cytosolic and secreted pools of caveolin
have also been described (Liu et al., 1999; Uittenbogaard et al.,
1998). Caveolins possess a 33-residue central hydrophobic
region (the intramembrane domain), which might form a
hairpin in the lipid bilayer, flanked by cytoplasmically exposed
N- and C-terminal domains (Figs 1, 3, 4). They are synthesised
cotranslationally on the rough endoplasmic reticulum (ER)
(Monier et al., 1995) and then, in most cells, appear to travel
along the secretory pathway to the plasma membrane (Pol et
al., 2005); although, see Uittenbogaard et al. for an alternative
trafficking model (Uittenbogaard et al., 1998). The transit of
caveolins through the Golgi complex is relatively slow
compared with that of other membrane proteins (Pol et al.,
2005; Ren et al., 2004), and so a Golgi pool of newly
synthesised caveolin can be visualised in most cell types
(Luetterforst et al., 1999; Nichols, 2002; Pol et al., 2005).
Transport of caveolin (but not other integral membrane
proteins) through the Golgi complex can be accelerated by
cholesterol (Pol et al., 2005). Caveolin-1 is palmitoylated on
multiple cysteine residues (Dietzen et al., 1995) in a late-Golgi
(BFA-sensitive) compartment (Parat and Fox, 2001) (Figs 1
and 4). This modification is not apparently required for further
transport of caveolin-1 or localisation to pre-existing caveolae
(Dietzen et al., 1995).
At some stage in the secretory pathway, caveolin changes
from a monomeric, detergent-soluble form to an oligomeric,
detergent-insoluble form (Pol et al., 2005). The presence of the
detergent-insoluble form suggests association with lipid raft
domains, although it is important to note that the use of
detergents to assess microdomain association has been
questioned (Lichtenberg et al., 2005; Munro, 2003). Amino
acid substitutions and truncations that disrupt trafficking to the
Fig. 3. Sequence features and disease-associated amino acid changes in caveolins-1 (Cav1) and -3 (Cav3). Some key amino acids and features
of caveolin-1 and caveolin-3 are shown in relation to defined domains of caveolin-1 and caveolin-3. Numbers above the lines indicate amino
acid number in mammalian caveolins. Palmitoylation sites (Palm) in caveolin-1 are indicated in green (potential sites in caveolin-3 are not
shown), phosphorylation sites (P) are shown in red, and the starting methionine (M33) of caveolin-1 is shown in black. Caveolin-3 residues
are numbered assuming a single methionine residue at the N-terminus. Disease-associated amino acid substitutions in caveolin-1 and caveolin-3
are shown in blue. Abbreviations: RMD, rippling muscle disease; DM, distal myopathy; FHCK, familial hyperCKaemia; SHCK, spontaneous
hyperCKaemia; MYO, myopathy; LGMD1C, limb girdle muscular dystrophy 1C; BC, breast cancer.
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cell surface cause accumulation of detergent-soluble caveolin
in the Golgi complex (Galbiati et al., 1999; Luetterforst et al.,
1999; Machleidt et al., 2000; Ren et al., 2004). Rather than
revealing cryptic Golgi-targeting or retention sites, these
mutations might perturb the caveolin structure, leading to
retention of misfolded caveolin in the Golgi complex (Ren et
al., 2004). This feature of caveolin mutants is important for
understanding certain disease states associated with both
caveolin-1 and caveolin-3 (Galbiati et al., 1999). In a recent
study, transport of caveolin mutants to the plasma membrane
correlated with their ability to associate with lipid raft domains
– determined by an in vitro detergent-insolubility assay. Those
mutants that accumulate in the Golgi complex generally show
reduced raft affinity in this assay (Ren et al., 2004). Thus,
incorporation into lipid raft domains in the Golgi complex
might be required for formation of caveolae in the Golgi
complex or transport of caveolin to the surface prior to their
formation.
The site of caveola formation
Where do caveolae form? Transient expression studies and
quantitative EM immunolabelling initially indicated that
caveolae might form at the plasma membrane by suggesting
that a threshold of caveolin is required at the plasma membrane
to generate caveolae (Fra et al., 1995). However, more-recent
light microscopy studies of the trafficking of newly synthesised
caveolin-1–GFP provided evidence for the formation of
caveolae in the Golgi complex (Tagawa et al., 2005). In the
latter experiments, the intensity of caveolin-1–GFP puncta
leaving the Golgi complex is similar to that in surface caveolae,
which suggests that ‘mature’ caveolae are assembled in the
Golgi complex. The caveolin-1–GFP-labelled structures
apparently fuse directly with the plasma membrane. The
caveolin-containing structures may therefore represent carriers
in a Golgi-to-plasma-membrane trafficking pathway distinct
from those carrying other exocytic markers, such as the
vesicular stomatitis virus (VSV) G protein (Tagawa et al.,
2005). If so, loss of caveolin-1 might cause a perturbation of
this pathway as a result of the absence of the caveolin carriers.
This is consistent with the disruption of the post-Golgi
transport of specific proteins by caveolin mutants and in cells
lacking caveolins (Hernández-Deviez et al., 2006; Wyse et al.,
2003).
Under normal conditions, the concentration of newly
synthesised endogenous caveolin in the Golgi complex is
presumably low [the half-life of caveolin-1 is estimated to be
>10 hours (Conrad et al., 1995; Dupree et al., 1993)] but a
Golgi pool of newly synthesised caveolin is clearly evident
(Dupree et al., 1993; Nichols, 2002; Pol et al., 2005). If
formation of caveolar carriers in the Golgi requires a threshold
level of caveolin, the slow net transit of endogenous caveolin
out of the Golgi complex might allow a sufficiently high level
of caveolin to be reached to allow oligomerisation, raft
association and formation of carriers. In this model, only fully
assembled caveolae would be efficiently transported out of the
Golgi complex to the plasma membrane. The characteristics of
the Golgi pool of caveolin at steady state
[detergent soluble, monomeric (Pol et al.,
2005)] would reflect this. Significantly, upon
leaving the Golgi complex or reaching the
plasma membrane, caveolin can no longer be
recognised by certain caveolin antibodies (Pol
et al., 2005). Cholesterol depletion restores its
reactivity with these antibodies, which
suggests a cholesterol-dependent change in
caveolin structure on leaving the Golgi
complex that would be consistent with the
above model.
Once caveolae are formed, they are
extremely stable. Fluorescence recovery after
photobleaching (FRAP) experiments using
Journal of Cell Science 119 (5)
Fig. 4. Topology model of caveolin-1. Helical and
buried regions have been predicted from primary
structure. The model assumes that charged groups
(green) have access to the membrane surface and
tryptophan residues (W) are hydrogen bonded.
Note that tryptophan residues stay within one
helical turn of either the cytosolic (W85, W98,
W128) or the exterior (W115) membrane interface.
Aromatic residues tend to stay together (black
numbers indicate their position in rotational
degrees relative to the first aromatic residue of
each segment). Segment 80-95 qualifies as an in-
plane amphipathic membrane anchor and might
compensate for the effect of segment 95-110 being
shorter than segment 110-130. Aromatic residues
are depicted in yellow, known surface accessible
residues in red, and the palmitoyl moieties are to
scale. (Numbers correspond to murine caveolin-1.)
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caveolin-GFP constructs show that caveolin does not diffuse
rapidly in the membrane (Pelkmans et al., 2004; Thomsen et
al., 2002) and caveolin molecules within individual caveolae
do not exchange with each other (Tagawa et al., 2005).
Moreover, real-time experiments have shown that caveolae are
relatively immobile. A small fraction can bud; this can be
accelerated under certain circumstances – for example,
triggering by binding of the virus SV40 or introduction of a
phosphatase inhibitor (Kirkham et al., 2005; Pelkmans et al.,
2004; Thomsen et al., 2002). Once internalised, caveolae can
fuse with a novel endosomal compartment, the caveosome
(Pelkmans et al., 2001) or early endosomes (Pelkmans et al.,
2004; Sharma et al., 2003; Tran et al., 1987) but remain as
discrete units, despite the release of their cargo into the
endosomal compartments (Pelkmans et al., 2004). Caveolae
can also fuse with the plasma membrane directly in a ‘kiss-
and-run’ cycle (Pelkmans and Zerial, 2005). A lack of surface
caveolae in some experiments could therefore reflect a change
in the endo/exocytic cycling of caveolae rather than the
inability of plasma membrane caveolins to form caveolae.
Additional proteins implicated in the formation of
caveolae
Quantitative studies of caveolin expression suggest that
additional factors are involved in the biogenesis of caveolae.
Caveolin-2 may regulate formation of caveolae driven by
caveolin-1, particularly in epithelial cells. In these cells,
caveolin-1 is detectable on both surfaces but caveolae generally
form only at the basolateral surface. Caveolin-2 is targeted
specifically to the basolateral surface (Scheiffele et al., 1998)
and interacts with caveolin-1; it could thus be involved in the
polarised formation of caveolae at the basolateral surface.
Evidence both for and against such a role exists.
Overexpression of caveolin-2 in Madin-Darby canine kidney
(MDCK) epithelial cells increases formation of caveolae at the
basolateral surface (Lahtinen et al., 2003). Furthermore, in a
caveolin-negative prostate cancer cell line, caveolin-1
expression is insufficient to generate caveolae but vesicles,
assumed to be related to caveolae, accumulate under the
plasma membrane (Sowa et al., 2003). Upon co-expression
with wild-type caveolin-2, but not caveolin-2 lacking key
phosphorylation sites, caveolae are produced. These findings
led to a model in which caveolin-2 phosphorylation on Ser23
and Ser36 by casein kinase 2 (or a related kinase) regulates
caveola formation. An alternative possibility, which might be
compatible with other in vivo and in vitro studies, is that
caveolae are very dynamic in this particular cell type. The
putative internal caveolae visualised in this study upon
caveolin-1 expression might represent budded caveolae, and
the lack of surface caveolae might reflect a change in their
endo/exocytic cycling. Caveolin-2 might negatively regulate
this process in a phosphorylation-dependent manner. With the
powerful systems now available to follow budding of caveolae
in real time (Pelkmans and Zerial, 2005) and quantitatively
assess budding of individual caveolae by EM (Kirkham et al.,
2005), this question can now be addressed.
A general role for caveolin-2 in driving caveola formation
appears unlikely. Caveolin-1 expressed at levels similar to
those observed in naturally expressing caveolin-containing cell
lines causes formation of caveolae in the absence of caveolin-
2 (Fra et al., 1995). Moreover, caveolin-2-null mice appear to
have normal caveolae in the tissues examined (Razani et al.,
2002b). Other studies have also shown no effect of caveolin-2
on the formation of caveolae when it is expressed together with
caveolin-1 (Breuza et al., 2002) or have shown that caveolin-2
causes formation of more-deeply invaginated caveolae
(Fujimoto et al., 2000).
Despite the striking morphology of interconnected caveolae
within the developing T-tubule system of muscle (Ishikawa,
1968; Parton et al., 1997), caveolin-3 alone causes formation
of caveolae identical to those formed by caveolin-1 when
expressed in a non-muscle system (Kirkham et al., 2005) (M.
Kirkham and R.G.P., unpublished). Additional, presumably
muscle-specific, factors must therefore help form this
specialised tubular system during muscle differentiation.
Amphiphysin 2/Bin1 (M-Amph2) might provide this role.
When expressed in fibroblasts, M-Amph2 generates long
surface-connected tubules to which caveolin is recruited (Lee
et al., 2002). In developing muscle, it partially colocalises with
caveolin-3 and binds to phosphatidylinositol (4,5)-
bisphosphate [PtdIns(4,5)P2], which is dramatically
upregulated during muscle differentiation (Lee et al., 2002).
Although caveolin-3 is not essential for T-tubule development,
the cooperation between caveola-generating caveolin-3 and
tubule-generating amphiphysin may be important for the
development of the characteristic beaded intermediates
involved in the generation of the mature T-tubule (Galbiati et
al., 2001; Lee et al., 2002).
The importance of cholesterol
Cholesterol is integral to the formation and maintenance of
caveolae. Early studies showed enrichment of sterols at the
neck of caveolae (Montesano, 1979). Depletion of cholesterol
causes flattening of caveolae (Rothberg et al., 1992;
Westermann et al., 2005) and an increase in mobility of
caveolin-1–GFP in the plasma membrane (Thomsen et al.,
2002). Caveolin binds cholesterol tightly in a 1:1 ratio (Murata
et al., 1995), and crosslinking studies using a photoactivatable
derivative of cholesterol show that it is a major cholesterol-
interacting protein (Thiele et al., 2000). Expression of caveolin
in cells lacking caveolae causes enrichment of cholesterol in a
low-density, detergent-insoluble floating fraction but the
increase is greater than predicted for a 1:1 caveolin-cholesterol
interaction (Pike et al., 2002).
The cholesterol-binding domain of caveolin has not yet been
pinpointed, but its scaffolding domain (residues 82-101 in
caveolin-1; Fig. 3), originally considered to be a protein-
interaction domain, is now thought to play a role in membrane
interactions. This highly conserved region of caveolin has
numerous bulky aromatic residues and key positively charged
residues (Figs 1, 4). Interestingly, expression of a dystrophy-
associated point mutant of caveolin-3 (C71W) (McNally et al.,
1998; de Paula et al., 2001) disrupts Ras signalling in a
cholesterol-dependent manner (Carozzi et al., 2002).
Substitution of tryptophan, rather than loss of cysteine, is
important for this effect (Carozzi et al., 2002), which suggests
that an additional tryptophan residue could influence
association of cholesterol with caveolae. This is an interesting
possibility given a recent in vitro study showing that
tryptophan-cholesterol interactions can modulate bilayer
curvature (van Duyl et al., 2005). Thus, the interaction of
caveolin with cholesterol may be fundamental to the generation
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of caveolae. Intriguingly, in a completely unrelated system, a
cysteine-to-tryptophan change (but not substitution by other
residues) in a lipid-exposed transmembrane segment of the
nicotinic acetylcholine receptor dramatically enhances the
response of the receptor to cholesterol modulation (Santiago et
al., 2001).
The N-terminal end of the scaffolding domain of caveolin-
1 contains a conserved serine residue (S80; Fig. 3) that plays
a role in regulating cholesterol binding. Phosphorylation of
S80 decreases caveolin-1-associated cholesterol whereas a
point mutant, S80A, shows increased sterol binding (Fielding
et al., 2004). Platelet-derived growth factor (PDGF) stimulates
phosphorylation of Y14 upon loss of sterol (Fielding et al.,
2004), which suggests that there are complex interactions
between different domains of caveolin-1 that link signal
transduction to cholesterol binding.
In vitro studies of caveolin-cholesterol interactions have
largely focused on the scaffolding domain of caveolin-1 (see
Figs 1, 3). The scaffolding domain might at least partially insert
into the membrane (Arbuzova et al., 2000) and form an in-
plane amphipathic helix with one face exposed (see below).
Cholesterol promotes the deeper insertion of the peptides into
the membrane but the strongest interaction involves the
interfacial region of the membrane. Caveolins contain a
potential cholesterol recognition and/or interaction amino acid
consensus (CRAC) motif (Li and Papadopoulos, 1998). CRAC
motifs have the consensus sequence L/V-(X)(1-5)-Y-(X)(1-5)-
R/K- (in which X represents any amino acid) and are present
in many proteins that interact with cholesterol (Li and
Papadopoulos, 1998). The CRAC motif in caveolin-1 (residues
94 to 101) has not been directly implicated in a simple 1:1
interaction with cholesterol. A comparison of three peptides
derived from this region of caveolin-1, one corresponding to
the entire scaffolding domain, a second shorter peptide
containing the CRAC motif (VTKYWFYR) and a third that
does not (KYWFYR) (Epand et al., 2005), shows that the two
CRAC-motif-containing peptides associate with liposomes,
insert into the membrane and promote segregation of
cholesterol into domains (Epand et al., 2005). The sequestered
cholesterol is present in crystalline complexes, which indicates
that the enrichment is not a result of peptide-cholesterol
binding but to an alteration of membrane properties that allows
cholesterol enrichment. Indeed, concentration of cholesterol in
caveolae is unlikely to reflect a simple 1:1 binding of
cholesterol to caveolin because cholesterol is in great excess
of any membrane protein.
These studies show that caveolin-cholesterol interactions are
complex but that caveolin could cause lateral segregation of
cholesterol in the membrane. How this operates in the context
of the entire caveolin molecule, which also interacts with the
membrane through its intramembrane domain and
palmitoylated C-terminus, has yet to be determined.
Nevertheless, we can speculate about how these and other
regions of caveolin could contribute to caveola formation by
drawing comparisons with other membrane-modelling
processes.
A model for formation of caveolae
If caveolins are the driving force for formation of caveolae,
how does this occur? As described above, one important
property of the caveolin-1 and caveolin-3 proteins is their
ability to self-associate to form higher-order homo-oligomeric
structures. Caveolin-1 forms a 350 kDa complex containing an
estimated 14-16 monomers of caveolin-1 (Monier et al., 1996;
Sargiacomo et al., 1995). The 41-residue stretch preceding the
putative intramembrane domain mediates homo-
oligomerisation of caveolin (Sargiacomo et al., 1995). In
addition, the C-terminus of caveolin-1 interacts with its N- and
C-terminal domains (Song et al., 1997) and this suggested an
elegant model for the generation of higher-order oligomeric
structures. Oligomer formation would allow formation of
discrete membrane domains enriched in caveolin. Whereas
oligomerisation is therefore likely to facilitate formation of
caveolae, this has not been directly demonstrated and one study
concluded that formation of caveolae driven by different
caveolin-1–caveolin-2 hybrids correlates with lipid raft
association not oligomerisation (Breuza et al., 2002).
How then could caveolin (in the form of monomers or
oligomers) modulate membrane curvature? To begin to tackle
this question, we have modelled the caveolin-membrane
interaction (Fig. 4). Caveolin-1 possesses a central
hydrophobic region encompassing both the scaffolding and
intramembrane domains (residues 80-130). Its membrane
association is likely to be limited on either side by
phosphorylation of S80 and palmitoylation of C133
respectively, two processes that probably require access to the
cytosol. Using a variety of algorithms, we found that the entire
region has high helical probabilities, residues 113-127 (within
the intramembrane domain) in particular displaying a plateau
(P>0.95) and exceptional hydrophobicity. We could also
predict the existence of an additional six-turn helix upstream
(1) between residues 30-50 (P>0.5) that has sharp boundaries
and alternates every half turn between buried and solvent-
exposed states, which is indicative of an interface helix. The
C-terminal residues 160-178 exhibit similar characteristics but
lower helical probabilities.
The second half of the hydrophobic region is routinely
identified as a transmembrane helix. Using whole-residue
hydrophobicity scales (Wimley and White, 1996), we found
that residues 110-130 clearly prefer the membrane’s
hydrocarbon interior to the interface and we assigned them to
helix 3. Helix 3 possesses a defined end, showing a sharp
drop in helical probability at position P132, a residue that
helical C-termini do not tolerate. The complete conservation of
P132 in caveolins indicates that this residue might be crucial
for a stable structure. Because prolines are present at N-termini
of known transmembrane helices, the start of helix 3 is
defined by the minimal length necessary to traverse the
membrane rather than by residue P110. Our assignment is
further supported by the evolutionary conservation of an
AxxxGxxxA motif following A112, which resembles the well-
known GxxxG motif of transmembrane helices (Russ and
Engelman, 2000) and might be required for the close
positioning of helices in hairpin structures. Moreover, helix 3
places W115 and W128 within one helical turn of the
membrane interface, which is consistent with experimental
evidence that tryptophan residues resist translocation into the
hydrocarbon core. W115 and W128 are separated by 12
residues, which places their respective C atoms ~1.8 nm
apart. Taking into account both the length of a hydrogen bond
(~0.3 nm) and the distance between N and C within a
tryptophan side chain (~0.4 nm), we can conclude that these
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12 residues are sufficient to allow both residues to contact lipid
head group carboxyl functions in opposing leaflets (~3.2 nm
apart). In addition, it has been suggested that tryptophan
residues interact with cholesterol by contacting the hydroxyl
group and aligning their imidazole moieties with the steroid
rings. Thus, in terms of both penetration depth and side-chain
orientation, W115 and W128 would be in an ideal position.
Modelling the remainder of the hydrophobic region (the
scaffolding domain and first half of the intramembrane domain
upstream of 3) is less straightforward. The experimental
evidence that the scaffolding domain participates in membrane
interaction (Arbuzova et al., 2000; Epand et al., 2005) makes
the hydrophobic region much longer than the 33-residue
intramembrane domain (102-134) originally proposed,
essentially eliminating the need for a hairpin structure. Because
a second pair of tryptophan residues (W85 and W98) spaced
12 residues apart is present, one could assign residues 81-101
to a single outbound helix 2 (not shown in Fig. 4). This would
raise the interesting possibility that caveolin-2 cannot form
caveolae because it lacks the two tryptophan residues in the
outer leaflet (W98 in helix 2 and W115 in helix 3). However,
we dismiss such a structure because it would connect the two
helices through a ten-residue loop (residues 99-109) containing
charged residues. This would be highly unfavoured when
caveolins localise to lipid droplets because these charges would
be placed inside their completely hydrophobic interior
(Ostermeyer et al., 2004). Alternatively, if a helical hairpin, i.e.
a tight turn connecting two -helices, were present, it would
require turn-forming residues to assume dihedral angles not
available to all amino acids. G108 and/or P110 are the only
nearby residues that have high turn potential (Monne et al.,
1999). However, helical probabilities and hydrophobicity
values rise immediately C-terminal of residue S80, which
would make helix 2 significantly longer than helix 3. Two
helices of 20 residues each would require a very tight turn at
a position with low turn propensities, position bulky residues
between both helices, and/or place charged residues and
tryptophan residues into the hydrocarbon core.
Modelling this 50-residue hydrophobic stretch into a
symmetrical structure that does not produce hydrophobic
mismatch and yet avoids energetically costly conformations
therefore constitutes a major difficulty. One particularly
interesting solution to this problem is to orientate region 80-95
(helix 2a) in the plane of the membrane, with all four aromatic
residues (F81, W85, F89, F92) pointing into the hydrocarbon
core and charged residues (D82 and K86) accessing the cytosol.
In this conformation, the diameter of helix 2a in combination
with the length of the remaining section (helix 2b) corresponds
to the length of helix 3. Interestingly, such in-plane helical
membrane anchors have been identified before, and a recent
algorithm indicates that the scaffolding domain, which inserts
into the interfacial region of the membrane and recruits
cholesterol (Arbuzova et al., 2000; Epand et al., 2005), is
compatible with such a structure (N. Sapay, Y. Guermeur and
G. Deléage, personal communication). We propose that
insertion of the scaffolding domain into the membrane is
necessary to trigger formation of a caveola. This might occur
in the late Golgi, which would be consistent with a cholesterol-
dependent conformational ‘maturation’ step that renders
specific caveolin epitopes inaccessible (Pol et al., 2005).
In contrast to the transient recruitment and regulated
assembly of coat proteins involved in the formation of clathrin-
coated pits and COP-coated buds, the association of caveolin
with the caveolar membrane is very stable and clearly quite
different. Yet analysis of vesicle formation in these systems and
their accessory proteins in particular can provide interesting
insights into possible mechanisms of formation of caveolae.
Epsin, for example, actually inserts into the bilayer to expand
the area of the cytoplasmic leaflet and so facilitates clathrin-
coated pit formation (Ford et al., 2002). Because estimates of
the number of caveolin molecules per caveola and the size of
cytoplasmic–lipid-raft domains suggest that caveolin–lipid-raft
microdomains could cover the entire cytoplasmic face of the
caveolar bulb, the high local concentration of caveolin in the
bilayer might likewise expand the cytoplasmic leaflet.
Tryptophan residues at the membrane interface could further
increase cholesterol recruitment and insertion of the
scaffolding domain into the membrane, achieving greater
expansion of the cytoplasmic leaflet of the caveolar bulb.
We have addressed this quantitatively by using standard
reference volumes (Harpaz et al., 1994) [refined in Tsai and
Gerstein (Tsai and Gerstein, 2002)] to calculate the lipid
volume such protein segments would displace (Fig. 5). We first
Fig. 5. Model of volume contributions from caveolin and cholesterol
in caveolae. The model estimates the increase in volume of the
hydrophobic core of the cytoplasmic leaflet (Vc) of the plasma
membrane compared with the hydrophobic core of the outer leaflet
(Vo) that would be required to cause the curvature characteristic of a
caveola. The diagram shows the ellipsoid shape of a fast-frozen
adipocyte caveola for which we obtained values of a=42 nm, b=33
nm, c=21 nm, h=29 nm. Vc and Vo were calculated by sequentially
subtracting the volumes of a set of three concentric ellipsoids
obtained by reducing the dimensions of a, b and c by t and 2t, where
t is the thickness of the hydrophobic core of a single leaflet (t=1.5
nm). The volume of a solid ellipsoid of the configuration shown is
given by V=/3 (2ab2+2hb2+hc2). We assume that only the
scaffolding domain helix 2a contributes to expansion of Vc because
the two membrane-spanning helices (2b and helix 3) contribute
equal volumes to Vc and Vo. We further assume that there are 145
caveolin molecules per caveola (Ncav) and that the volume of 2a,
V2a=2.2 nm3. We propose that the additional volume required to
expand the cytoplasmic leaflet (Vc–Vo) is contributed by the ability of
the scaffolding domain to penetrate the hydrophobic core of the
cytoplasmic leaflet and sequester cholesterol in an asymmetric
fashion across the bilayer. Nchol is the number of cholesterol
molecules sequestered by caveolin, and we assume that the volume
of a cholesterol molecule is 0.612 nm3. In this model, the volume
contributed by cholesterol, Vchol, would correspond to a molecular
ratio of cholesterol to caveolin of 13:1.
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calculated the volumes of the inner and outer leaflet of a typical
caveolar membrane and compared the relative volume increase
of the cytosolic leaflet with the volume contributed by caveolin
and cholesterol. We assume that only the scaffolding domain
(helix 2a) contributes to expansion of the cytosolic leaflet
(Vc) because the two membrane-spanning helices (2b and
helix 3) contribute equal volumes to the inner and outer
leaflets of the membrane. These calculations indicate that
confinement of the scaffolding domain within the cytosolic
leaflet (Fig. 4), together with about 13 molecules of cholesterol
per caveolin monomer, could indeed suffice to generate the
curvature observed in caveolar invaginations (Fig. 5).
Cholesterol clearly plays an important role in the formation
of caveolae but its concentration in the cytoplasmic leaflet of
the curved caveolar bulb is energetically less favourable owing
to its negative spontaneous curvature (van Duyl et al., 2005).
Differences in the lengths of the transmembrane segments of
caveolin might therefore be functionally important. For
instance, a negative hydrophobic mismatch of helix 2b and/or
the insertion of the scaffolding domain as an in-plane helix can
generate local membrane deformations that have positive
curvature, thus stabilising cholesterol in the vicinity (van Duyl
et al., 2005). Alternatively, this could create a curved protein
surface, as in the case of amphiphysin, in which membrane
curvature is generated through the electrostatic interaction
between phospholipids and the concave surface of the BAR
(Bin/amphiphysin/Rvs) domain (Peter et al., 2004). Helices of
unequal lengths could also produce structural perturbations
(Ren et al., 2004) that have effects elsewhere: these could be
responsible for the slow net transit out of the Golgi complex,
in which caveolin cycling could facilitate caveolin-caveolin
and caveolin-cholesterol interactions required for formation of
caveolae.
Clearly, many aspects of this model require validation. The
absence of structural data on caveolins prevents detailed
mechanistic insights at present but the high density of caveolin
in the caveolar membrane (Dupree et al., 1993) and the
association of caveolin with lipid rafts are certainly consistent
with a structural model in which caveolin-cholesterol
interactions drive caveolae formation. Our model can also
accommodate regulatory mechanisms. For instance,
phosphorylation of S80 might cause relocations as a result of
changed electrostatics and desolvation energies. The role of
this modification and of other specific amino acids can now be
tested in relation to the proposed model.
Concluding remarks
Caveolae represent a stable membrane unit built up around
caveolin and cholesterol-rich domains in a late Golgi
compartment. Caveolin-membrane interactions, and
specifically insertion of the scaffolding domain into the
membrane and its interaction with cholesterol, might provide
the driving force for generation of the unique caveolar
structure. This process must also be subject to regulation;
recent high-throughput studies of caveolae internalisation
implicate kinases in the regulation of caveolin assembly and
disassembly (Pelkmans et al., 2005; Pelkmans and Zerial,
2005). Downregulation of the kinase ARAF1, for example,
causes loss of caveolin from caveolae and an increase in
caveolin mobility. Detailed molecular dissection of these
effects is now possible. High-resolution structural analysis of
caveolae and in vitro reconstitution of caveolae formation will
also provide new insights into the molecular mechanisms
involved. This will have general implications for the
understanding of membrane morphogenesis as well as
providing specific insights into caveola-related disease.
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